Walgreens to Pay $595 Million in Settlement Over COVID-19 Testing Dispute

Pieter Gunst01 mins

On February 25, 2025, it was disclosed in a U.S. Securities and Exchange Commission filing that Walgreens Boots Alliance Inc. has reached an agreement to pay $595 million to a lab testing and diagnostics company. This settlement resolves ongoing litigation concerning COVID-19 testing practices. The financial agreement follows disputes that arose during the unprecedented demand for COVID-19 testing services at the height of the pandemic. To delve deeper into the specifics of the case and understand the implications of the settlement, you can read more in the detailed report available at Law360.